Northwestern University Feinberg School of Medicine

Adam Sonabend Lab


The following is a list of the top 50 publications by Adam Sonabend. For the full list, please click here.
  1. Kinslow CJ, Bruce SS, Rae AI, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Sonabend AM, Wang TJC  Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study.  J Neurooncol  2018 Feb 09;. doi:10.1007/s11060-018-2787-7
  2. Tai CH, Wu CC, Hwang ME, Saraf A, Grubb C, Jani A, Lapa ME, Andrews JIS, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJ  Single institution validation of a modified graded prognostic assessment of patients with breast cancer brain metastases.  CNS Oncol  2018 Jan;7(1):25-34. doi:10.2217/cns-2017-0023
  3. Yun J, Yang J, Cloney M, Mehta A, Singh S, Iwamoto FM, Neugut AI, Sonabend AM  Assessing the Safety of Craniotomy for Resection of Primary Central Nervous System Lymphoma: A Nationwide Inpatient Sample Analysis.  Front Neurol  2017;8:478. doi:10.3389/fneur.2017.00478
  4. Wu CC, Chaudhary KR, Na YH, Welch D, Black PJ, Sonabend AM, Canoll P, Saenger YM, Wang TJC, Wuu CS, Hei TK, Cheng SK  Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.  Int J Radiat Oncol Biol Phys  2017 09 01;99(1):191-201. pii:S0360-3016(17)30913-6
  5. Saraf A, Grubb CS, Hwang ME, Tai CH, Wu CC, Jani A, Lapa ME, Andrews JIS, Vanderkelen S, Isaacson SR, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Cheng SK, Connolly EP, Wang TJC  Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.  J Neurooncol  2017 Sep;134(2):453-463. doi:10.1007/s11060-017-2549-y
  6. Kinslow CJ, Rajpara RS, Wu CC, Bruce SS, Canoll PD, Wang SH, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Bruce JN, Wang TJC  Invasiveness is associated with metastasis and decreased survival in hemangiopericytoma of the central nervous system.  J Neurooncol  2017 Jun;133(2):409-417. doi:10.1007/s11060-017-2450-8
  7. Mehta AM, Sonabend AM, Bruce JN  Convection-Enhanced Delivery.  Neurotherapeutics  2017 04;14(2):358-371. doi:10.1007/s13311-017-0520-4
  8. Chang PD, Malone HR, Bowden SG, Chow DS, Gill BJA, Ung TH, Samanamud J, Englander ZK, Sonabend AM, Sheth SA, McKhann GM, Sisti MB, Schwartz LH, Lignelli A, Grinband J, Bruce JN, Canoll P  A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies.  AJNR Am J Neuroradiol  2017 May;38(5):890-898. doi:10.3174/ajnr.A5112
  9. Yun J, Iwamoto FM, Sonabend AM  Primary Central Nervous System Lymphoma: A Critical Review of the Role of Surgery for Resection.  Arch Cancer Res  2016;4(2). pii:71
  10. Cloney MB, Sonabend AM, Yun J, Yang J, Iwamoto F, Singh S, Bhagat G, Canoll P, Zanazzi G, Bruce JN, Sisti M, Sheth S, Connolly ES, McKhann G  The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis.  J Neurooncol  2017 03;132(1):189-197. doi:10.1007/s11060-016-2358-8
  11. Sonabend AM, Bowden S, Bruce JN  Microsurgical resection of pineal region tumors.  J Neurooncol  2016 11;130(2):351-366
  12. Sonabend AM, Zacharia BE, Cloney MB, Sonabend A, Showers C, Ebiana V, Nazarian M, Swanson KR, Baldock A, Brem H, Bruce JN, Butler W, Cahill DP, Carter B, Orringer DA, Roberts DW, Sagher O, Sanai N, Schwartz TH, Silbergeld DL, Sisti MB, Thompson RC, Waziri AE, McKhann G  Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle Study.  Neurosurgery  2017 Apr 01;80(4):590-601. doi:10.1227/NEU.0000000000001374
  13. Cloney M, D'Amico R, Lebovic J, Nazarian M, Zacharia BE, Sisti MB, Bruce JN, McKhann GM, Iwamoto FM, Sonabend AM  Frailty in Geriatric Glioblastoma Patients: A Predictor of Operative Morbidity and Outcome.  World Neurosurg  2016 May;89:362-7. doi:10.1016/j.wneu.2015.12.096
  14. Spence NZ, Faloba K, Sonabend AM, Bruce JN, Anastasian ZH  Venous air embolus during scalp incision.  J Clin Neurosci  2016 Jun;28:170-1. doi:10.1016/j.jocn.2015.11.019
  15. Lieber BA, Appelboom G, Taylor BE, Lowy FD, Bruce EM, Sonabend AM, Kellner C, Connolly ES, Bruce JN  Preoperative chemotherapy and corticosteroids: independent predictors of cranial surgical-site infections.  J Neurosurg  2016 Jul;125(1):187-95. doi:10.3171/2015.4.JNS142719
  16. Sonabend AM, McKhann GM  Boosting Dendritic Cell Vaccination for Glioblastoma Using Tetanus Toxoid.  Neurosurgery  2015 Aug;77(2):N20-1. doi:10.1227/01.neu.0000467298.64128.e7
  17. D'Amico RS, Cloney MB, Sonabend AM, Zacharia B, Nazarian MN, Iwamoto FM, Sisti MB, Bruce JN, McKhann GM  The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma.  World Neurosurg  2015 Oct;84(4):913-9. doi:10.1016/j.wneu.2015.05.072
  18. Baldock AL, Ahn S, Rockne R, Johnston S, Neal M, Corwin D, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, Lai A, Cloughesy T, McKhann GM, Bruce JN, Rostomily RC, Canoll P, Swanson KR  Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.  PLoS One  2014;9(10):e99057. doi:10.1371/journal.pone.0099057
  19. Baldock AL, Yagle K, Born DE, Ahn S, Trister AD, Neal M, Johnston SK, Bridge CA, Basanta D, Scott J, Malone H, Sonabend AM, Canoll P, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR  Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.  Neuro Oncol  2014 Jun;16(6):779-86. doi:10.1093/neuonc/nou027
  20. Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI, Bruce JN  Response.  J Neurosurg  2014 Feb;120(2):298-9
  21. Sonabend AM, Carminucci AS, Amendolara B, Bansal M, Leung R, Lei L, Realubit R, Li H, Karan C, Yun J, Showers C, Rothcock R, O J, Califano A, Canoll P, Bruce JN  Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.  Neuro Oncol  2014 Sep;16(9):1210-9. doi:10.1093/neuonc/nou026
  22. Sonabend AM, Bansal M, Guarnieri P, Lei L, Amendolara B, Soderquist C, Leung R, Yun J, Kennedy B, Sisti J, Bruce S, Bruce R, Shakya R, Ludwig T, Rosenfeld S, Sims PA, Bruce JN, Califano A, Canoll P  The transcriptional regulatory network of proneural glioma determines the genetic alterations selected during tumor progression.  Cancer Res  2014 Mar 01;74(5):1440-1451. doi:10.1158/0008-5472.CAN-13-2150
  23. Sonabend AM, Zacharia BE, Goldstein H, Bruce SS, Hershman D, Neugut AI, Bruce JN  The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis.  J Neurosurg  2014 Feb;120(2):300-8. doi:10.3171/2013.10.JNS13113
  24. Sonabend AM, Bruce JN  Management paradigms along a histologic spectrum of pineal cell tumors.  World Neurosurg  ;81(5-6):685-7. doi:10.1016/j.wneu.2013.07.096
  25. Sonabend AM, Yun J, Lei L, Leung R, Soderquist C, Crisman C, Gill BJ, Carminucci A, Sisti J, Castelli M, Sims PA, Bruce JN, Canoll P  Murine cell line model of proneural glioma for evaluation of anti-tumor therapies.  J Neurooncol  2013 May;112(3):375-82. doi:10.1007/s11060-013-1082-x
  26. Yun J, Sonabend AM, Ulasov IV, Kim DH, Rozhkova EA, Novosad V, Dashnaw S, Brown T, Canoll P, Bruce JN, Lesniak MS  A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery.  J Clin Neurosci  2012 Jun;19(6):875-80. doi:10.1016/j.jocn.2011.12.016
  27. Sonabend AM, Ogden AT, Maier LM, Anderson DE, Canoll P, Bruce JN, Anderson RC  Medulloblasoma: challenges for effective immunotherapy.  J Neurooncol  2012 May;108(1):1-10. doi:10.1007/s11060-011-0776-1
  28. Goldstein H, Sonabend AM, Connolly ES  Chronic subdural hematomas: perspective on current treatment paradigms.  World Neurosurg  2012 Jul;78(1-2):66-8. doi:10.1016/j.wneu.2011.10.004
  29. Sonabend AM, Stuart RM, Yun J, Yanagihara T, Mohajed H, Dashnaw S, Bruce SS, Brown T, Romanov A, Sebastian M, Arias-Mendoza F, Bagiella E, Canoll P, Bruce JN  Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump.  Neuro Oncol  2011 Aug;13(8):886-93. doi:10.1093/neuonc/nor051
  30. Lei L, Sonabend AM, Guarnieri P, Soderquist C, Ludwig T, Rosenfeld S, Bruce JN, Canoll P  Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype.  PLoS One  2011;6(5):e20041. doi:10.1371/journal.pone.0020041
  31. Sonabend AM, Korenfeld Y, Crisman C, Badjatia N, Mayer SA, Connolly ES  Prevention of ventriculostomy-related infections with prophylactic antibiotics and antibiotic-coated external ventricular drains: a systematic review.  Neurosurgery  2011 Apr;68(4):996-1005. doi:10.1227/NEU.0b013e3182096d84
  32. Ulasov IV, Nandi S, Dey M, Sonabend AM, Lesniak MS  Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.  Mol Med  ;17(1-2):103-12. doi:10.2119/molmed.2010.00062
  33. Dey M, Ulasov IV, Tyler MA, Sonabend AM, Lesniak MS  Cancer stem cells: the final frontier for glioma virotherapy.  Stem Cell Rev  2011 Mar;7(1):119-29. doi:10.1007/s12015-010-9132-7
  34. Kranzler J, Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS  Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.  Curr Gene Ther  2009 Oct;9(5):389-95
  35. Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS  Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.  Br J Cancer  2009 Apr 07;100(7):1154-64. doi:10.1038/sj.bjc.6604969
  36. Tyler MA, Ulasov IV, Sonabend AM, Nandi S, Han Y, Marler S, Roth J, Lesniak MS  Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.  Gene Ther  2009 Feb;16(2):262-78. doi:10.1038/gt.2008.165
  37. Sonabend AM, Ulasov IV, Han Y, Rolle CE, Nandi S, Cao D, Tyler MA, Lesniak MS  Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats.  Cancer Gene Ther  2009 Apr;16(4):362-72. doi:10.1038/cgt.2008.80
  38. Sonabend AM, Rolle CE, Lesniak MS  The role of regulatory T cells in malignant glioma.  Anticancer Res  ;28(2B):1143-50
  39. Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS  Vector therapies for malignant glioma: shifting the clinical paradigm.  Expert Opin Drug Deliv  2008 Apr;5(4):445-58. doi:10.1517/17425247.5.4.445
  40. Sonabend AM, Ulasov IV, Tyler MA, Rivera AA, Mathis JM, Lesniak MS  Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma.  Stem Cells  2008 Mar;26(3):831-41. doi:10.1634/stemcells.2007-0758
  41. Sonabend AM, Ulasov IV, Lesniak MS  Emerging role of new transgenic mouse models in glioma research.  Expert Rev Anticancer Ther  2007 Dec;7(12 Suppl):S7-13. doi:10.1586/14737140.7.12s.S7
  42. Sonabend AM, Dana K, Lesniak MS  Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.  Expert Rev Anticancer Ther  2007 Dec;7(12 Suppl):S45-50. doi:10.1586/14737140.7.12s.S45
  43. Sonabend AM, Velicu S, Ulasov IV, Han Y, Tyler B, Brem H, Matar MM, Fewell JG, Anwer K, Lesniak MS  A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma.  Anticancer Drugs  2008 Feb;19(2):133-42. doi:10.1097/CAD.0b013e3282f24017
  44. Kushen MC, Sonabend AM, Lesniak MS  Current immunotherapeutic strategies for central nervous system tumors.  Surg Oncol Clin N Am  2007 Oct;16(4):987-1004, xii
  45. Ulasov IV, Rivera AA, Nettelbeck DM, Rivera LB, Mathis JM, Sonabend AM, Tyler M, Wang M, Douglas JT, Lesniak MS  An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.  Int J Oncol  2007 Nov;31(5):1177-85
  46. Sonabend AM, Ulasov IV, Lesniak MS  Gene therapy trials for the treatment of high-grade gliomas.  Gene Ther Mol Biol  2007;11(A):79-92
  47. Ulasov IV, Rivera AA, Sonabend AM, Rivera LB, Wang M, Zhu ZB, Lesniak MS  Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.  Cancer Biol Ther  2007 May;6(5):679-85
  48. Musleh W, Sonabend AM, Lesniak MS  Role of craniotomy in the management of pituitary adenomas and sellar/parasellar tumors.  Expert Rev Anticancer Ther  2006 Sep;6 Suppl 9:S79-83
  49. Sonabend AM, Musleh W, Lesniak MS  Oncogenesis and mutagenesis of pituitary tumors.  Expert Rev Anticancer Ther  2006 Sep;6 Suppl 9:S3-14
  50. Tyler MA, Ulasov IV, Borovjagin A, Sonabend AM, Khramtsov A, Han Y, Dent P, Fisher PB, Curiel DT, Lesniak MS  Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus.  Mol Cancer Ther  2006 Sep;5(9):2408-16